Your shopping cart is currently empty

SUN B8155 is a calcitonin (CT) receptor agonist that selectively mimics the biological effects of calcitonin and induces cAMP formation in cells expressing recombinant human CT receptor.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 2 mg | $149 | - | In Stock |
| Description | SUN B8155 is a calcitonin (CT) receptor agonist that selectively mimics the biological effects of calcitonin and induces cAMP formation in cells expressing recombinant human CT receptor. |
| Targets&IC50 | cAMP:21 μM (EC50) |
| In vitro | SUN B8155 (1-1000 μM, 1 hr treatment) promoted intracellular cAMP production in a concentration-dependent manner in T47D cells, with cAMP levels increasing approximately 42-fold at the highest concentration. The compound also increased cAMP production in the UMR106-06 cell line derived from rat osteogenic sarcoma. In CHO/hPTHR or CHO parental cells, SUN B8155 was unable to trigger cAMP production. However, in CHO/hCTR cells, SUN B8155 significantly enhanced cAMP generation in a concentration-dependent manner with an EC50 of 21 μM. [1] |
| In vivo | Intraperitoneal injection of SUN B8155 (100 mg/kg) resulted in a significant decrease in serum calcium concentration of approximately 9% at 30 minutes post-dose.[1] |
| Synonyms | SUN-B 8155 |
| Molecular Weight | 273.29 |
| Formula | C14H15N3O3 |
| Cas No. | 345893-91-6 |
| Smiles | O=C1C=C(C(=C(O)N1O)C(=NC=2C=CC=CC2N)C)C |
| Relative Density. | 1.34 g/cm3 (Predicted) |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| Solubility Information | DMSO: 80 mg/mL (292.73 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
| In Vivo Formulation | 10% DMSO+90% Saline: 3.3 mg/mL (12.08 mM), Sonication is recommended. Please add the solvents sequentially, clarifying the solution as much as possible before adding the next one. Dissolve by heating and/or sonication if necessary. Working solution is recommended to be prepared and used immediately. The formulation provided above is for reference purposes only. In vivo formulations may vary and should be modified based on specific experimental conditions. | |||||||||||||||||||||||||||||||||||
Solution Preparation Table | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.